Regulation of Genome Editing in Human iPS Cells
A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies
The book provides a concise overview of currently applicable regulatory frameworks of states which are among the world leaders in research and development (R&D) of cell and gene therapies. Developments in genome editing are expected to lead to new possibilities for the treatment of hereditary diseases in humans. The treatment of such often severe but hitherto uncurable diseases can be based on genome-edited induced pluripotent stem cells (iPS cells). Such treatments constitute combined cell/gene therapies. These therapies need to be governed by a regulatory framework which ensures quality, safety, and efficacy of the relevant therapeutic…
Mehr
CHF 179.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V104:
Folgt in ca. 10 Arbeitstagen
Produktdetails
Weitere Autoren: Dederer, Hans-Georg (Hrsg.)
- ISBN: 978-3-030-93022-6
- EAN: 9783030930226
- Produktnummer: 38998971
- Verlag: Springer International Publishing
- Sprache: Englisch
- Erscheinungsjahr: 2022
- Seitenangabe: 344 S.
- Masse: H24.1 cm x B16.0 cm x D2.4 cm 682 g
- Auflage: 1st ed. 2022
- Abbildungen: HC runder Rücken kaschiert
- Gewicht: 682
Über den Autor
Hans-Georg Dederer is a full professor and holder of the Chair of Constitutional and Administrative Law, Public International Law, European and International Economic Law at the University of Passau (Germany). His fields of research include biotechnology law. He is also a member of the Permanent Senate Commission on Genetic Research of the German Research Foundation (Deutsche Forschungsgemeinschaft - DFG).Gregor Frenken is a teaching and research assistant in the Chair of Constitutional and Administrative Law, Public International Law, European and International Economic Law at the University of Passau (Germany).
Bewertungen
Anmelden